Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Intimation Of Schedule Of Investor/Analyst Meetings On June 11, 2018

 Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the details of investor/analyst meetings scheduled on June 11, 2018. The schedule may undergo change due to exigencies on the part of Investors/Analysts/ Company. We also enclose the presentation to be used during the meetings. This is for your kind information and records.
08-06-2018
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jubilant Stock Holding Pvt Ltd
30-05-2018

Jubilant Life gets USFDA nod for Niacin extended release tablets

 The approval granted by the USFDA to Jubilant Pharma is for multiple strengths of Niacin extended-release tablets of 500 mg, 750 mg, and 1,000 mg
15-05-2018
Bigul

USFDA Approval

 We enclose a communication pertaining to USFDA approval.
15-05-2018
Bigul

Announcement under Regulation 30 (LODR)-Newspaper Publication

 In continuation of our letter dated May 9, 2018, we enclose copies of the Audited Consolidated Financial Results for the quarter and year ended March 31, 2018 published on May 10, 2018 in MINT (English) and HINDUSTAN (Hindi).
10-05-2018
Bigul

Issuance Of Commercial Papers Of Rs. 80 Crore

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company has issued Commercial Papers ('CPs') of Rs. 80 crore on May 10, 2018.
10-05-2018
Bigul

Compliance With Regulation 52(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 We enclose a certificate dated May 9, 2018 received from Vistra ITCL (India) Limited, Debenture Trustee, pursuant to Regulation 52 (5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the Non-Convertible Debentures of the Company listed on National Stock Exchange of India Limited. We request you to take the same on record.
09-05-2018
Bigul

Announcement under Regulation 30 (LODR)-Dividend Updates

 Dear Sirs, Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has, at its meeting held today i.e. on May 9, 2018, recommended a dividend of Rs. 3 (Rupees Three only) per equity share of Re.1 each for the year ended March 31, 2018. The dividend, if approved by the shareholders...
09-05-2018
Bigul

Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended March 31, 2018

 Dear Sirs, In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2018 were approved by the Board of Directors of the Company at its meeting held today at 2.00 p.m. and concluded at 3.00 p.m....
09-05-2018
Bigul

Annual report for Jubilant Life Sciences Ltd. for FY-2018
09-05-2018
Next Page
Close

Let's Open Free Demat Account